January 6, 2017

The number of drugs the FDA approved last year, 22, is less than half of the 45 approved in 2015 and lower than the average of the last 10 years of approvals, which is 29. 

January 4, 2017

DSN associate editor David Salazar examines the state of the pharmacy industry in this multi-page report.

January 4, 2017

The one truth a new Trump Administration and a Republican Congress represents is change, and for some, that spells opportunity.

January 4, 2017

New site features members-only section featuring alerts, announcements and documents.

January 4, 2017

As is typical of an industry tied so closely to legislation and the markets, the state of retail pharmacy is typically one in flux. With 2016 in the rearview mirror and both 2017 and a new presidential administration ahead, what are the biggest changes facing the industry?

January 4, 2017

Senate votes 51-48 in favor of beginning a debate on a budget resolution that would overhaul Obamacare.

January 4, 2017

In her decision, the Honourable Justice Michèle Monast ruled that the royalty clauses in all the Jean Coutu Group’s franchise agreements are legal.

January 4, 2017

DSN talks to the NACDS CEO and president about life, leadership and where he finds inspiration for both.

January 4, 2017

A return to big blockbuster drug introductions. A renewed focus on innovation. A more favorable climate for merger-and-acquisition activity. Those are some examples of what a Donald Trump White House could mean for the pharmaceutical industry.

December 16, 2016

CHPA works to reduce teen DXM abuse by following three strategies: increase parent engagement, heighten teen perception of risk and social disapproval and limit teen access to DXM.

December 16, 2016

Using blood glucose data wirelessly transmitted from the OneTouch Verio Flex blood glucose monitoring system, WellDoc's patented clinical and behavioral engine will provide patients with individualized real-time feedback.

December 14, 2016

Over the coming months Neighbourhood Pharmacies will be encouraging federal and provincial lawmakers to enact legislation and regulations that ensure Canadians use medical marijuana as intended.

December 13, 2016

William Tighe named as vice president of federal government affairs and Amber Manko as director of federal government affairs.

December 13, 2016

The act will invest more than $6 billion over seven years to provide funding for various initiatives, including fighting prescription drug abuse, expanding the president’s Precision Medication Initiative and funding the “cancer moonshot,” aimed at finding new and better treatments for cancer.

December 9, 2016

“We advise the public to be cautious when reviewing [adverse event] reports and to consider the fuller picture,” CRN cautioned.

December 8, 2016

As part of an agreement with the DOJ, GNC will take a number of actions to broaden industry-wide knowledge of prohibited ingredients and improve compliance by vendors of third party products.

December 7, 2016

President Obama said in his Dec. 3 weekly address that he would sign the legislation into law "as soon as it reaches my desk."

December 7, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of automation and technology, in this multi-page report.

December 7, 2016

The FDA has cited that hearing loss affects some 30 million people in the United States and can have a significant impact on communication, social participation and overall health and quality of life.

December 7, 2016

NCPA addressed several areas where independent community pharmacies and the patients they serve could be adversely affected by the pharmacy “lock-in” provision in the opioid abuse legislation.

December 6, 2016

Drug Store News caught up with NACDS president and CEO Steve Anderson for a recap of 2016 and a look ahead at what to expect from a Trump administration.

DSN: What is the RxImpact scorecard for 2016? How did the industry do on the key pharmacy and patient access issues?

December 6, 2016

The bottom line behind President-elect Donald Trump’s proposals: The cost burden of the $3 trillion industry will shift away from the federal government and toward private enterprise, state government and consumers.

December 5, 2016

Schloss is an experienced and accomplished executive with two decades of experience in federal government affairs, most recently at Mylan helping direct their Congressional outreach efforts.

December 5, 2016
The Food and Drug Administration’s director of the Center for Drug Evaluation and Research, Dr. Janet Woodcock, said that the agency would conduct a national search to fill the vacancy left by retiring Office of New Drugs director Dr. John Jenkins, and that in the interim, she would be acting director of the OND.